Release Date: 15/09/09 10:07 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 11.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%